Glycomics Market: By Product (Enzymes, Instruments, Kits, and Reagents), Application (Diagnostics, Drug Discovery & Development, Oncology, Immunology, Other Applications), End- User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations), and Geography - Glycomics Market Report Description

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Glycomics Market size was expected to be worth USD 924.5 million in 2022 and is projected to grow at a 15.3% CAGR from 2023 to 2029. The study of saccharides, which are extensively found in nature and are also thought of as glycans, and their structure, biology, and function is known as glycomics or glycobiology. Glycans are found in all living organisms. Glycobiology is a rapidly progressing biological area of interest for various fields like biotechnology, biomedicine, and basic research. Most proteins are revised after the translation process in eukaryotic cells. The attachment of glycans is one of the most usual modifications for cell viability. The Enzymes segment is anticipated to grow at a significant CAGR over the forecast years due to the consumable nature of enzymes and their wide applications in a variety of R&D and drug discovery procedures. The glycose of a tissue, cell, or organism can be quantified or defined using a variety of research techniques in Glycosmis. The final glycan structure changes because of changes in location or the activity of the enzymes involved in glycan production. As a result, in addition to genetic markers for people, glycan analysis may be used to evaluate alterations brought on by the environment. This research can be used to find new medicines and diagnose diseases. One of the main drivers of segment expansion is this. Increase in demand for research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment are a few factors driving the industry's growth over the forecasting period.

Glycomics Market Key Developments:

In June 2019, Agilent Technologies (US) has launched InfinityLab LC/MSD iQ System.
In June 2018, Thermo Fisher Scientific (US) had launched UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer.

Glycomics Market Summary

Study Period

2023– 2029

Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Glycomics Market Dynamics

The rising government funding in research and the creation of innovative treatments by pharmaceutical and biotechnology businesses. Furthermore, increased interest in glycomics and proteomics research investigations is expected to drive market development in the forcasting period. Rising government and organisation investments have enabled university researchers to create novel glycomics and glycobiology technologies. This aspect is expected to propel the glycomics market, and therefore the total industry. Advanced analytical approaches for understanding pathogen and human glycobiology in illness and health are required in glycoproteomic. Hence, there has been a rise in biomedical and proteomics research, leading to the growth of this market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Glycomics Market Segmentation

By Product Type
  • Enzymes
  • Instruments
  • Kits
  • Reagents
By Application
  • Diagnostics
  • Drug Discovery & Development
  • Oncology, Immunology
  • Other Applications
By End User
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA


Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Merck KGaA (Germany)
  • Agilent Technologies (US)
  • Thermo Fisher Scientific (US)
  • New England Biolabs (US)
  • Shimadzu Corporation (Japan)
  • Takara Bio (Japan)
  • S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • Waters Corporation (US)
  • Asparia Glycomics S.L. (Spain)
  • Bio-Techne (US)
  • Bruker Corporation (US)
  • Danaher Corporation (US)
  • RayBiotech (US)
  • Z Biotech (US)
  • Chemily Glycoscience (US)